1-13 of 13
Debra Czerwinski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

Holbrook E. Kohrt, Ariane Thielens, Aurelien Marabelle, Idit Sagiv-Barfi, Caroline Sola, Fabien Chanuc, Nicolas Fuseri, Cécile Bonnafous, Debra Czerwinski, Amanda Rajapaksa, Erin Waller, Sophie Ugolini, Eric Vivier, François Romagné, Ronald Levy, Mathieu Bléry, Pascale André
Journal: Blood
Blood (2014) 123 (5): 678–686.
https://doi.org/10.1182/blood-2013-08-519199
Published: 2014
Includes: Supplemental data
Journal Articles

Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation

Holbrook E. Kohrt, Antonia Müller, Jeanette Baker, Matthew J. Goldstein, Evan Newell, Suparna Dutt, Debra Czerwinski, Robert Lowsky, Samuel Strober
Journal: Blood
Blood (2011) 118 (19): 5319–5329.
https://doi.org/10.1182/blood-2011-05-356238
Published: 2011
Includes: Supplemental data
Journal Articles

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Kipp Weiskopf, Ash A. Alizadeh, Josh Brody, Antonia Müller, Russell Pachynski, Debra Czerwinski, Steven Coutre, Mark P. Chao, Lieping Chen, Thomas F. Tedder, Ronald Levy
Journal: Blood
Blood (2011) 117 (8): 2423–2432.
https://doi.org/10.1182/blood-2010-08-301945
Published: 2011
Includes: Supplemental data
Journal Articles

NF-κB Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome

June Helen Myklebust, PhD, Jonathan Michael Irish, PhD, Joshua Brody, MD, Ash A. Alizadeh, MD/PhD, Debra Czerwinski, Roch Houot, MD, PhD, Holbrook E Kohrt, MD, Arne Kolstad, MD, PhD, Ronald Levy, MD
Journal: Blood
Blood (2010) 116 (21): 144.
https://doi.org/10.1182/blood.V116.21.144.144
Published: 2010
Journal Articles

In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study

Youn H. Kim, MD, Dita Gratzinger, MD, PhD, Cameron Harrison, MD, Joshua Brody, MD, Debra Czerwinski, Leon Xing, Anjali Morales, MD, PhD, Weiyun Ai, MD, PhD, Farah Abdulla, MD, Daniel Navi, MD, Robert J. Tibshirani, PhD, Ranjana Advani, MD, Yasodha Natkunam, MD, PhD, Richard T. Hoppe, MD, Ron Levy, MD
Journal: Blood
Blood (2010) 116 (21): 286.
https://doi.org/10.1182/blood.V116.21.286.286
Published: 2010
Journal Articles

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma

Brief Report
Weiyun Z. Ai, Robert Tibshirani, Behnaz Taidi, Debra Czerwinski, Ronald Levy
Journal: Blood
Blood (2009) 113 (23): 5743–5746.
https://doi.org/10.1182/blood-2009-01-201988
Published: 2009
Includes: Supplemental data
Journal Articles

Combined Treatment with Short Synthetic Anti-Lymphoma Peptide and CpG ODN; A Therapeutic Vaccine Which cures the A20 Lymphoma in Balb/C Mice.

Arne Kolstad, MD, PhD, Roch Houot, MD, Gerd Berge, Øystein Rekdal, PhD, Debra Czerwinski, PhD, Matthew Goldstein, Joshua Brody, MD, R. Levy
Journal: Blood
Blood (2008) 112 (11): 1586.
https://doi.org/10.1182/blood.V112.11.1586.1586
Published: 2008
Journal Articles

Anti-Idiotype Antibody Response after Vaccination Correlates with Better Overall Survival in Follicular Lymphoma.

Wei Z. Ai, MD, PhD, Robert Tibshirani, PhD, Behnaz Taidi, Bsc, Debra Czerwinski, Bsc, Ronald Levy, MD
Journal: Blood
Blood (2007) 110 (11): 647.
https://doi.org/10.1182/blood.V110.11.647.647
Published: 2007
Journal Articles

Tumor-Infiltrating T Cells Are Not Predictive of Clinical Outcome in Follicular Lymphoma.

Wei Yun Z. Ai, MD, PhD, Debra Czerwinski, Bsc, Sandra J. Horning, MD, John Allen, Bsc, Robert Tibshirani, PhD, Ronald Levy, MD
Journal: Blood
Blood (2006) 108 (11): 824.
https://doi.org/10.1182/blood.V108.11.824.824
Published: 2006
Journal Articles

Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy

Clinical Trials & Observations Brief Report
Wen-Kai Weng, Debra Czerwinski, Ronald Levy
Journal: Blood
Blood (2006) 109 (3): 951–953.
https://doi.org/10.1182/blood-2006-03-013136
Published: 2006
Includes: Supplemental data
Journal Articles

Use of Dendritic Cells and GM-CSF Adjuvant Are Associated with Anti-Idiotype Cellular Immune Response Following Idiotype Vaccination in Follicular Lymphoma Patients.

Wen-Kai Weng, MD, PhD, Debra Czerwinski, Ronald Levy, MD
Journal: Blood
Blood (2005) 106 (11): 771.
https://doi.org/10.1182/blood.V106.11.771.771
Published: 2005
Journal Articles

Humoral Immune Response and Immunoglobulin G Fc Receptor Genotype Are Associated with Better Clinical Outcome Following Idiotype Vaccination in Follicular Lymphoma Patients Regardless of Their Response to Induction Chemotherapy.

Wen-Kai Weng, MD, PhD, Debra Czerwinski, Ronald Levy, MD
Journal: Blood
Blood (2005) 106 (11): 777.
https://doi.org/10.1182/blood.V106.11.777.777
Published: 2005
Journal Articles

Tumor-Specific Idiotype Vaccines in the Treatment of Patients With B-Cell Lymphoma — Long-Term Results of a Clinical Trial

Frank J. Hsu, Clemens B. Caspar, Debra Czerwinski, Larry W. Kwak, Tina Marie Liles, Athanasia Syrengelas, Behnaz Taidi-Laskowski, Ronald Levy
Journal: Blood
Blood (1997) 89 (9): 3129–3135.
https://doi.org/10.1182/blood.V89.9.3129
Published: 1997